The Cigna Group (CI)
5 HMO Stocks to Watch Amid Steady Premium Flow, Increased Digitization
An aging U.S. population, digital transformation, a diversified membership mix and strategic M&A are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.
Cigna (CI) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Investors Should Stay Neutral on Cigna Stock for Now
CI's growth and shareholder returns are weighed against rising costs, medical expenses and debt, keeping investors neutral for now.
Cigna: I'm Buying What Others Are Ignoring
Cigna Group remains a "Buy," with double-digit adjusted EPS growth intact and shares trading 28% below fair value. CI's Accredo and AI-powered Pharmacy Forward platforms are key growth drivers, supporting robust revenue and margin expansion through 2028. The company boasts an A- S&P credit rating, strong free cash flow, and a secure, growing dividend with low payout ratios.
Why Cigna (CI) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Cigna (CI) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cigna's Valuation Gap Still Stands Out
Cigna (CI) maintains a Buy rating as valuation remains deeply discounted despite steady earnings growth and raised guidance. CI lifted 2026 adjusted EPS guidance to at least $30.45, targeting 10% EPS growth and mid-single-digit revenue growth through 2027. Capital returns continue with $6.3 billion in cash, ongoing buybacks, and a $1.56 per share dividend, supported by strong operating cash flow.
Cigna Group Q2 Earnings Call Highlights
Cigna Group NYSE: CI raised its full-year 2026 adjusted earnings outlook after reporting second-quarter results that management said exceeded expectations in both its Evernorth health services business and Cigna Healthcare insurance segment.
CI Q2 Earnings Beat Estimates on Cigna Healthcare Strength
Cigna delivers an earnings and revenue beat as Cigna Healthcare fuels growth, while the company raises its 2026 EPS outlook despite higher pharmacy costs.
Cigna (CI) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
The Cigna Group (CI) Q2 2026 Earnings Call Transcript
The Cigna Group (CI) Q2 2026 Earnings Call Transcript
Cigna (CI) Q2 Earnings and Revenues Top Estimates
Cigna (CI) came out with quarterly earnings of $7.78 per share, beating the Zacks Consensus Estimate of $7.58 per share. This compares to earnings of $7.2 per share a year ago.
